363 related articles for article (PubMed ID: 19765454)
21. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
22. [Histological statistics of malignant urogenital tumors].
Shimada K; Nishizaki S; Taguchi K; Matsui T; Okamoto S; Yabumoto H; Kanokogi M; Mori Y; Ikoma F
Hinyokika Kiyo; 1984 May; 30(5):651-5. PubMed ID: 6089534
[TBL] [Abstract][Full Text] [Related]
23. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
24. Development of urologic de novo malignancies after renal transplantation.
Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
[TBL] [Abstract][Full Text] [Related]
25. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte subsets in renal transplant recipients with de novo genitourinary malignancies.
Guichard G; Rebibou JM; Ducloux D; Simula-Faivre D; Tiberghien P; Chalopin JM; Bittard H; Saas P; Kleinclauss F
Urol Int; 2008; 80(3):257-63. PubMed ID: 18480627
[TBL] [Abstract][Full Text] [Related]
27. Prostatic tumors in Iran.
Habibi A; Manouchehri A; Diba MH; Sajadi M; Ghavam M
Int Surg; 1975 Aug; 60(8):405-7. PubMed ID: 1158617
[TBL] [Abstract][Full Text] [Related]
28. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
Wright JL; Hotaling J; Porter MP
J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
[TBL] [Abstract][Full Text] [Related]
29. [Renal transplantation and malignancies: A single-centre experience (25 years)].
Stefoni S; Scolari MP; Sestigiani E; Faenza A; Campieri C; Buscaroli A; Liviano D'Arcangelo G; D'Addio F
G Ital Nefrol; 2002; 19(6):650-7. PubMed ID: 12508170
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
32. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries.
Fischer CG; Waechter W; Kraus S; Fuentecilla Perez E; Weidner W; Dudeck J
Cancer; 1998 Feb; 82(4):775-83. PubMed ID: 9477112
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of prostate cancers in renal-transplant recipients.
Cormier L; Lechevallier E; Barrou B; Benoit G; Bensadoun H; Boudjema K; Descottes JL; Doré B; Guy L; Malavaud B; Martin X; Patard JJ; Petit J; Salomon L
Transplantation; 2003 Jan; 75(2):237-9. PubMed ID: 12548131
[TBL] [Abstract][Full Text] [Related]
34. A matched case-control study on the prognosis of native kidney neoplasia in renal transplant recipients.
Grochowiecki T; Szmidt J; Nazarewski S; Galazka Z; Durlik M; Borkowski T; Borkowski A; Wojtaszek M
Transpl Int; 2002 Oct; 15(9-10):455-8. PubMed ID: 12389076
[TBL] [Abstract][Full Text] [Related]
35. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
[TBL] [Abstract][Full Text] [Related]
36. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
37. Novel blood biomarkers of human urinary bladder cancer.
Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
[TBL] [Abstract][Full Text] [Related]
38. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
[TBL] [Abstract][Full Text] [Related]
39. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
Kim DY; Abouljoud M; Parasuraman R
Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
